Topical microbicides for preventing sexually transmitted infections-Reference-Cited by-同舟云学术

Topical microbicides for preventing sexually transmitted infections

Published:2021-03-13 Issue:3 Volume:2021 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Obiero Jael¹,Ogongo Paul²,Mwethera Peter G³,Wiysonge Charles S⁴

Affiliation:

1. Department of Reproductive Health and Biology; Institute of Primate Research; Nairobi Kenya

2. Tropical and Infectious Diseases; Institute of Primate Research; Nairobi Kenya

3. Head, Reproductive Health & Biology; Institute of Primate Research; Nairobi Kenya

4. Cochrane South Africa; South African Medical Research Council; Cape Town South Africa

Publisher

Wiley

Subject

Pharmacology (medical)

Reference93 articles.

1. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women;Abdool Karim;Science,2010

2. Tenofovir gel for the prevention of herpes simplex virus type 2 infection;Abdool Karim;New England Journal of Medicine 2015,2015

3. Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial;Karim;Trials,2011

4. Keller DM AIDS 2010, XVIII International AIDS Conference: Tenofovir vaginal gel first microbicide to prevent HIV, HSV infections Medscape Medical News

5. Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women;Abdool Karim;AIDS,2011

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical assessment of an antibiotic-free cationic surfactant-based cellulose hydrogel for sexually and perinatally transmitted infections;Matter;2024-06

2. Associations between intravaginal practices and incidence of sexually transmitted infections and bacterial vaginosis among women enrolled in the dapivirine vaginal ring trial (The Ring Study) in southwestern Uganda: a retrospective secondary analysis;BMJ Open;2024-04

3. PRO-2000 exhibits SARS-CoV-2 antiviral activity by interfering with spike-heparin binding;Antiviral Research;2023-09

4. Update on the Epidemiology, Screening, and Management of Chlamydia trachomatis Infection;Infectious Disease Clinics of North America;2023-06

5. Addressing HIV Misconceptions among Heterosexual Black Men and Communities in Ontario;Healthcare;2023-03-31